Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript
Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST
Company Participants
Bianca Buck – Finance & Head of Investor Relations
Daniel Perez – Co-Founder, CEO & Director
James Pursley – President
Aaryn Pure – Chief Commercial Officer
James Budge – Chief Financial Officer
Conference Call Participants
Elizabeth Anderson – Evercore ISI Institutional Equities, Research Division
Saket Kalia – Barclays Bank PLC, Research Division
Jailendra Singh – Truist Securities, Inc., Research Division
David Grossman – Stifel, Nicolaus & Company, Incorporated, Research Division
Ryan MacDonald – Needham & Company, LLC, Research Division
Jessica Tassan – Piper Sandler & Co., Research Division
Craig Hettenbach – Morgan Stanley, Research Division
Scott Schoenhaus – KeyBanc Capital Markets Inc., Research Division
Corey DeVito – Wells Fargo Securities, LLC, Research Division
John Granville Pinney – Canaccord Genuity Corp., Research Division
Tomer Zilberman – BofA Securities, Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to the Hinge Health Third Quarter 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Bianca Buck, Head of Investor Relations. Bianca, please go ahead.
Bianca Buck
Finance & Head of Investor Relations
Good afternoon, and welcome to Hinge Health’s Third Quarter 2026 Earnings Call. I’m Bianca Buck, Head of Investor Relations. With me on the call are Daniel Perez, our Co-Founder and CEO; Jim Pursley, our President; Aaryn Pure, our Chief Commercial Officer; and James Budge, our CFO. I want to thank everyone for joining us. As a reminder, this conference call is being recorded. All relevant materials are available on the Investor Relations section of our website.
Today’s discussion will include forward-looking statements, which are subject to various risks, uncertainties and assumptions. These statements reflect our current views and expectations regarding future events, including expected performance of our business, future financial results and growth strategies. While these statements represent our good faith judgment and beliefs, actual results
